LEADER 02247nam  2200613 a 450 
001 9910451838003321
005 20200520144314.0
010   $a1-280-38023-3
010   $a9786613558145
010   $a0-309-22555-8
035   $a(CKB)2550000000102948
035   $a(SSID)ssj0000648372
035   $a(PQKBManifestationID)11442402
035   $a(PQKBTitleCode)TC0000648372
035   $a(PQKBWorkID)10617186
035   $a(PQKB)11695043
035   $a(MiAaPQ)EBC3378973
035   $a(Au-PeEL)EBL3378973
035   $a(CaPaEBR)ebr10557792
035   $a(CaONFJC)MIL355814
035   $a(OCoLC)923287520
035   $a(EXLCZ)992550000000102948
100   $a20120517d2012      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aAlzheimer's diagnostic guideline validation$b[electronic resource] $eexploration of next steps : workshop summary /$fDiane E. Pankevich, Theresa Wizemann, and Bruce M. Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders ; Board on Health Sciences Policy, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$d2012
215   $axi, 26 p. $cill
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-22554-X 
320   $aIncludes bibliographical references.
606   $aAlzheimer's disease$xResearch$vCongresses
606   $aAlzheimer's disease$xTreatment$vCongresses
606   $aDiagnostic imaging$vCongresses
608   $aElectronic books.
615  0$aAlzheimer's disease$xResearch
615  0$aAlzheimer's disease$xTreatment
615  0$aDiagnostic imaging
676   $a616.8/31
701   $aPankevich$b Diane E$0966687
701   $aWizemann$b Theresa M$0890630
701   $aAltevogt$b Bruce M$0856949
712 02$aInstitute of Medicine (U.S.).$bForum on Neuroscience and Nervous System Disorders.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910451838003321
996   $aAlzheimer's diagnostic guideline validation$92193830
997   $aUNINA